Corewell Health is seeing positive results from its partnership with Nudj Health, a startup that delivers virtual lifestyle medicine programs. More than 3,600 Corewell patients have enrolled in Nudj’s programs since 2023 — and their reported improvements include weight loss, reduced depression and anxiety levels, better cholesterol and triglyceride levels, and increased daily exercise minutes….
Novartis is getting Tourmaline Bio’s pacibekitug, a Phase 3-ready antibody drug in development for atherosclerotic cardiovascular disease (ASCVD). Tourmaline licensed pacibekitug from Pfizer, which remains eligible for milestone payments tied to the progress of the drug. The post Novartis’s $1.4B Tourmaline Acquisition Brings Heart Drug That Could Rival Novo Nordisk, CSL Meds appeared first on…
These stories don’t just influence individual decisions; they have the power to shift perceptions, drive treatment adoption, and reignite purpose across entire organizations. The post The Most Powerful Tool in Healthcare Marketing: A Patient’s Voice appeared first on MedCity News.
Here are three things healthcare leaders should consider for improving the DME process to make the hospital-to-home experience more efficient and less stressful for all stakeholders. The post From Hospital to Home Without the Headaches: How Technology Can Smooth the Transition appeared first on MedCity News.
A federal judge has allowed key claims in Particle Health’s antitrust lawsuit against Epic to move forward, marking the first time such allegations against the EHR giant have gotten this far. The case centers on Epic’s alleged use of its influence over the Carequality data exchange to block Particle’s access to patient records and stifle…
Takeda Pharmaceutical’s oveporexton is designed to treat the root cause of narcolepsy. Statistically significant Phase 3 results for the twice daily pill were presented Monday during the World Sleep 2025 Congress in Singapore. The post Takeda Is Waking Up the Narcolepsy Market With First-in-Class Drug, But Alkermes Is on Its Heels appeared first on MedCity…
WeightWatchers’ new menopause program provides support from menopause-trained clinicians, along with workshops, fitness guidance and access to prescriptions when needed. The post WeightWatchers Introduces New Menopause Program appeared first on MedCity News.
Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit’s drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It’s the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. The post Summit Lung…
Testosterone deficiency deserves the same attention we give to any other age-related health concern. Providers can play a big role by starting the conversation when a patient brings up things like low energy, mood changes or reduced sex drive. The post Why Hormone Health Should Be A Standard Part Of Men’s Healthcare appeared first on…
The bill clarifies very specific patient protections and codifies a Patient’s Bill of Rights, all of which would ensure that individuals receiving supplemental oxygen in the home – and their suppliers – understand requirements around equipment, communications, and care options. The post SOAR Act Would Help Individuals Relying on Oxygen Thrive appeared first on MedCity…